- Endocyte, Inc. ECYT shares jumped 56.2 percent to $5.67 following 157 percent rally on Monday amid news of global license for PSMA-617. Wedbush upgraded Endocyte from Neutral to Outperform.
- Cesca Therapeutics Inc KOOL shares surged 42.2 percent to $5.12 after the company reported an allowance for US Patent application covering a novel method of cell separation.
- SG Blocks, Inc. SGBX shares rose 22.1 percent to $5.25 as the company reported securing of 2 low-income housing development projects in NY State.
- Vical Incorporated VICL shares gained 21.5 percent to $3.11 after the company reported VL-2397 approval by the FDA for Limited Use Indication.
- TDH Holdings Inc PETZ shares rose 19.7 percent to $27.31.
- Manhattan Associates, Inc. MANH surged 13.7 percent to $49.11. SunTrust Robinson Humphrey upgraded Manhattan Associates from Hold to Buy.
- RMG Networks Holding Corporation RMGN shares climbed 10.8 percent to $2.39. RMG reported the launch of a powerful, next-generation SaaS-based content management platform — Korbyt™.
- Myovant Sciences Ltd MYOV shares rose 9.7 percent to $16.10. Myovant Sciences reported successful results from a Takeda study of relugolix.
- Conifer Holdings Inc CNFR shares surged 8.4 percent to $6.50. Conifer Holdings reported a reinsurance agreement with Swiss Re to cover loss development up to $17.5 million in excess of June 30 reserves.
- CareDx Inc CDNA shares rose 7.8 percent to $4.29. CareDx reported an offering for 3.6 million shares of common stock.
- DryShips Inc. DRYS shares gained 7.3 percent to $2.96.
- Arbutus Biopharma Corp ABUS shares jumped 7.1 percent to $7.76. Roivant Sciences disclosed a 29.1 percent stake in Arbutus Biopharma.
- Westport Fuel Systems Inc (USA) WPRT shares rose 7 percent to $3.38.
- Cal-Maine Foods Inc CALM gained 3.4 percent to $43.07. Stephens & Co. upgraded Cal-Maine from Equal-Weight to Overweight.
- Paychex, Inc. PAYX rose 3.1 percent to $61.69 after the company reported better-than-expected earnings for its first quarter.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
